sudden
outbreak
sever
acut
respiratori
syndrom
sar
prompt
establish
global
scientif
network
subsum
tradit
rivalri
competit
field
virolog
within
month
sar
outbreak
collabor
work
reveal
ident
disastr
pathogen
sarsassoci
coronaviru
sarscov
howev
although
rapid
identif
agent
repres
import
breakthrough
understand
deadli
viru
remain
limit
detail
biolog
knowledg
crucial
develop
effect
countermeasur
diagnost
test
vaccin
antivir
drug
sarscov
articl
review
present
state
molecular
knowledg
sarscov
aspect
compar
genom
molecular
biolog
viral
gene
evolut
epidemiolog
describ
diagnost
test
antivir
drug
deriv
far
base
avail
molecular
inform
first
sar
case
report
late
china
guangdong
provinc
diseas
contagi
spread
rapidli
result
sar
outbreak
hong
kong
midfebruari
outbreak
elsewher
world
end
march
viru
coronavirida
famili
identifi
caus
agent
diseas
identif
confirm
world
health
organ
viru
concern
design
sarsassoci
coronaviru
sarscov
sar
outbreak
sar
case
identifi
countri
total
individu
becam
infect
die
http
wwwwhoint
addit
cost
human
live
sar
outbreak
also
great
impact
health
care
system
economi
hong
kong
infect
region
hong
kong
estim
econom
loss
hk
billion
us
billion
ref
possibl
sarscov
transmiss
occur
human
be
without
reinforc
correspond
author
email
fcleung
hkucchkuhk
anim
reservoir
capabl
viru
infect
multipl
cell
type
anim
increas
epidemiolog
burden
sar
pandem
although
spread
viru
seem
confin
juli
rigor
quarantin
measur
http
may
still
circul
anim
reservoir
imposs
say
return
possibl
better
monitor
sar
outbreak
accur
diagnost
test
develop
effect
antivir
therapi
urgent
requir
turn
depend
better
molecular
knowledg
sarscov
research
therefor
vital
import
commun
properli
prepar
possibl
recurr
sar
pandem
etiolog
entiti
viral
infect
reli
molecular
tradit
virolog
method
includ
serolog
techniqu
viru
isol
cell
cultur
electron
microscopi
molecular
approach
convent
approach
employ
initi
character
sar
pathogen
peiri
et
al
firstli
isol
viru
vitro
tissu
cultur
subsequ
yield
genom
fragment
rtpcr
use
degener
primer
show
homolog
rna
polymeras
gene
bovin
coronaviru
bcv
murin
hepat
viru
mhv
use
gene
chip
confirm
coronaviru
possibl
caus
sar
soon
identif
sarscov
laboratori
start
investig
phylogenet
relationship
viru
member
famili
extens
comparison
genom
sequenc
midapril
british
columbia
cancer
agenc
bcca
genom
scienc
center
canada
center
diseas
control
unit
state
univers
hong
kong
announc
nearli
time
complet
genom
sequenc
sarscov
isol
correspond
area
result
independ
sequenc
sarscov
genom
indic
polyadenyl
genom
rna
kb
length
compar
analysi
genom
coronavirus
suggest
viru
genom
similar
previous
character
coronavirus
order
start
ntermin
replicas
r
spike
envelop
e
membran
nucleocapsid
n
gene
accessori
gene
motif
span
structur
gene
utr
untransl
region
may
necessari
viral
replic
replicas
gene
two
open
read
frame
orf
cover
two
third
genom
predict
encod
two
proteinas
regul
replic
positivestrand
genom
rna
subsequ
transcript
nest
set
eight
subgenom
sg
mrna
tabl
ref
common
transcript
strategi
adopt
coronaviru
member
utr
sarscov
genom
character
rapid
amplif
cdna
end
race
ref
northern
blot
assay
procedur
elucid
leader
sequenc
transcript
regulatori
sequenc
tr
leader
sequenc
found
viral
sg
mrna
transcript
least
nucleotid
long
align
leader
sequenc
end
eight
sg
mrna
minim
consensu
tr
name
particip
discontinu
synthesi
sg
mrna
signal
sequenc
degre
sequenc
varianc
flank
tr
show
clear
relationship
abund
sg
mrna
highli
conserv
motif
nucleotid
also
identifi
region
genom
also
describ
avian
infecti
bronchiti
viru
aibv
ref
replicas
gene
sarscov
encod
least
two
protein
consequ
proteolyt
process
larg
polyprotein
orf
ref
translat
segment
polyprotein
interrupt
ribosom
frame
shift
put
slipperi
sequenc
put
pseudoknot
structur
two
function
domainspapainlik
cystein
proteinas
pro
cystein
proteinas
pro
identifi
experiment
respons
proteolyt
process
polyprotein
subunit
sarscov
uniqu
domain
identifi
upstream
pro
domain
unparallel
known
coronavirus
addit
seven
put
region
encod
rna
process
enzym
identifi
name
rnadepend
rna
polymeras
rdrp
rna
helicas
hel
poli
u
specif
endoribonucleas
xendou
exonucleas
exon
sadenosylmethioninedepend
ribos
adenosin
diphosphateribos
adrp
cyclic
phosphodiesteras
cpd
ref
translat
two
polyprotein
orf
start
genom
express
two
proteinas
pro
pro
coupl
proteolyt
process
two
polyprotein
unit
pro
respons
nproxim
cleavag
pro
respons
cproxim
cleavag
helicas
releas
atpas
activ
dna
duplexunwind
activ
demonstr
purifi
helicas
indic
protein
rna
polymeras
activ
togeth
protein
spike
protein
believ
incorpor
viral
envelop
matur
virion
releas
initi
analysi
peplom
protein
viru
reveal
possibl
exist
signal
peptid
would
like
cleav
residu
whole
structur
predict
contain
receptorbind
unit
nterminu
transmembran
unit
cterminu
molecular
model
subunit
spike
glycoprotein
suggest
former
unit
consist
mainli
antiparallel
dispers
region
addit
three
domain
identifi
unit
confid
level
predict
molecular
model
strengthen
good
correl
predict
access
hydropathi
profil
correct
locat
noglycosyl
site
disulfid
bridg
whether
experiment
determin
nglycosyl
site
purifi
spike
protein
treat
tryptic
digest
togeth
pngase
follow
timeofflight
tof
mass
spectrometri
correctli
locat
propos
model
remain
clarifi
aspect
biolog
activ
receptor
bind
sarscov
remain
mysteri
compar
genom
point
signific
similar
domain
human
coronavirus
impli
virus
use
differ
receptor
cell
entri
subsequ
angiotensinconvert
enzym
demonstr
function
receptor
sarscov
vitro
synctia
observ
cell
cultur
express
sarscov
domain
could
inhibit
antibodi
fine
map
ntermin
unit
spike
protein
indic
receptorbind
domain
probabl
locat
residu
sequenc
gene
product
orf
show
homolog
known
protein
signal
peptid
cleav
site
like
present
protein
except
three
predict
transmembran
domain
exact
function
protein
yet
determin
though
ctermin
protein
may
involv
atpbind
properti
envelop
protein
sarscov
thought
compon
viru
envelop
topolog
predict
suggest
e
protein
type
ii
membran
protein
cterminu
hydrophil
domain
expos
virion
surfac
compar
protein
sequenc
analysi
suggest
sarscov
e
protein
resembl
protein
connect
mhv
matrix
glycoprotein
like
cleav
contain
three
put
transmembran
domain
hydrophil
domain
believ
interact
nucleocapsid
protein
locat
insid
viru
particl
linear
epitop
map
protein
use
synthet
peptid
reveal
amino
acid
residu
interact
sar
patient
sera
elisa
assay
impli
potenti
capabl
protein
induc
immun
respons
like
orf
sequenc
homolog
search
yield
signific
result
exist
protein
exist
cleavag
site
residu
transmembran
helix
predict
orf
put
type
membran
protein
n
gene
sequenc
show
high
homolog
nucleocapsid
protein
coronavirus
put
short
lysinerich
nuclear
local
signal
ktfpptepkkdkkkktdeaq
identifi
potenti
wellconserv
rna
interact
domain
also
identifi
middl
region
gene
basic
natur
may
assist
role
n
protein
report
activ
signal
transduct
pathway
indic
protein
may
play
role
regul
host
cell
cycl
apart
possibl
role
pathogen
n
gene
also
believ
abund
antigen
host
cours
infect
make
excel
candid
diagnost
purpos
linear
epitop
protein
map
possibl
use
antigen
peptid
recombin
protein
diagnosi
discuss
phylogenet
relationship
comparison
deduc
amino
acid
sequenc
replicas
gene
four
structur
gene
e
n
coronavirus
describ
conclus
drawn
differ
research
group
similar
observ
sarscov
form
distinct
clusterth
fourth
group
coronavirida
notion
support
high
bootstrap
valu
result
conclud
sarscov
phylogenet
equidist
known
coronavirus
moreov
detect
recombin
event
conclud
similar
plot
whole
genom
align
coronavirus
find
suggest
sarscov
neither
mutant
recombin
exist
coronavirus
possibl
viru
emerg
product
genet
engin
exclud
unlik
gener
infecti
coronaviru
genom
differ
exist
coronavirus
snijder
et
al
conduct
extens
phylogenet
analysi
concern
replicas
gene
sarscov
use
toroviru
outgroup
author
critic
phylogram
construct
base
differ
sarscov
protein
unconvinc
suggest
possibl
sarscov
cluster
exist
group
structur
accessori
gene
either
gain
lost
throughout
evolutionari
process
view
low
level
conserv
author
decid
target
replicas
gene
perform
phylogenet
analysi
reason
phylogenet
relationship
reconstruct
root
tree
construct
phylogram
done
fuse
replicas
gene
manual
adjust
exclus
poorli
conserv
region
result
tree
reveal
gene
mostli
relat
group
coronavirus
assign
subgroup
author
point
sarscov
contain
homologu
domain
uniqu
group
coronavirus
region
pro
addit
differ
sequenc
arrang
locat
orf
lack
antigen
crossreact
contradict
conclus
phenomenon
also
observ
group
coronavirus
use
bayesian
phylogen
infer
approach
recombin
break
point
within
sarscov
rdrp
identifi
protein
sequenc
level
phylogenet
analysi
end
domain
indic
might
origin
common
ancestor
exist
coronavirus
analysi
end
gave
anoth
tree
topolog
suggest
sister
relationship
group
avian
coronavirus
result
suggest
recombin
event
occur
common
ancestor
sarscov
coronavirus
altern
fragment
sarscov
diverg
one
within
known
coronavirus
fragment
diverg
recent
base
antigen
cross
reactiv
genom
characterist
exist
coronavirus
gener
classifi
three
subgroup
coronavirus
share
similar
organ
function
structur
gene
arrang
socal
nonessenti
gene
remark
differ
among
subgroup
group
coronavirus
mainli
character
presenc
orf
follow
n
gene
group
coronavirus
two
addit
orf
nonstructur
protein
gene
locat
orf
gene
group
speci
orf
locat
n
gene
conserv
stemloop
motif
utr
figur
accessori
orf
found
e
gene
subgroup
howev
accessori
orf
within
se
intergen
region
seem
homolog
subgroup
though
conserv
within
subgroup
rate
evolut
accessori
gene
obvious
higher
essenti
gene
provid
altern
access
phylogeni
coronaviru
famili
name
groupspecif
accessori
orf
unifi
denot
top
correspond
subgroup
orf
x
black
cross
repres
absenc
orf
within
region
genom
organ
accessori
orf
cov
confirm
except
phev
accessori
gene
groupspecif
highli
diverg
within
subgroup
particular
within
intergen
region
sarscov
similar
genom
structur
group
cov
two
orf
locat
n
gene
conserv
stemloop
motif
utr
although
orf
group
cov
orf
sarscov
homolog
locat
signific
sequenc
homolog
base
confirm
orf
sarscov
describ
comparison
homolog
accessori
essenti
orf
known
coronavirus
novel
sarscov
shown
figur
result
seem
code
region
consequ
newli
occur
recombin
event
exist
known
coronavirus
similar
conclus
made
holm
interestingli
sarscov
genom
similar
organ
group
avian
coronavirus
ibv
tcv
presenc
three
orf
within
mn
intergen
region
two
orf
span
e
gene
stemloop
motif
utr
presenc
find
fragment
sarscov
rdrp
cluster
group
phylogenet
analysi
suggest
avian
coronavirus
sarscov
might
share
common
ancestor
gain
singl
rna
horizont
transfer
event
nonrel
viru
famili
astrovirus
anoth
possibl
common
coronaviru
ancestor
gain
motif
subsequ
lost
except
group
sarscov
cours
exclud
pairwis
sequenc
homolog
search
among
accessori
orf
se
intergen
region
sarscov
coronavirus
show
signific
sequenc
homolog
homolog
within
subgroup
orf
group
coronavirus
orf
sarscov
homolog
locat
signific
sequenc
homolog
result
impli
although
sarscov
group
coronavirus
similar
genom
organ
might
acquir
accessori
gene
sever
rna
recombin
event
differ
host
viral
sourc
observ
accessori
orf
groupspecif
usual
truncat
differ
extent
within
subgroup
figur
anoth
interest
observ
genet
divers
se
intergen
region
usual
two
three
groupspecif
orf
found
within
region
subgroup
one
confirm
orf
orf
found
region
sarscov
genom
divers
mainli
due
truncat
delet
se
intergen
orf
within
subgroup
higher
accessori
orf
sequenc
diverg
impli
common
ancestor
might
acquir
orf
rna
recombin
common
phenomenon
larg
rna
virus
rather
evolv
mutat
singl
ancestr
rna
sequenc
segment
typic
exampl
acquir
gene
influenza
c
recombin
event
bern
viru
region
base
recombin
truncat
event
occur
within
intergen
region
phylogenet
relationship
sarscov
group
coronavirus
reconstruct
figur
least
four
subgroup
common
ancestor
figur
acquir
se
intergen
orf
groupspecif
orf
sever
independ
rna
recombin
event
moreov
tendenc
delet
truncat
orf
cross
speci
barrier
within
subgroup
eg
orf
group
orf
orf
group
delet
redund
accessori
orf
like
result
rather
caus
cross
host
barrier
coronaviru
host
rang
specif
tropism
demonstr
least
four
studi
determin
receptorbind
domain
spike
glycoprotein
recombin
within
certain
type
virus
common
phenomenon
variou
viru
famili
particularli
larg
rna
virus
mean
shed
deleteri
effect
error
accumul
genom
replic
recombin
event
within
coronaviru
famili
nonrel
viru
famili
report
appar
divers
redund
accessori
gene
accompani
extens
genom
rearrang
heterogen
homogen
rna
recombin
event
provid
use
inform
taxonomi
coronavirus
point
view
sarscov
definit
new
uniqu
member
coronaviru
famili
diverg
redund
orf
sarscov
known
coronavirus
suggest
sarscov
might
circul
anim
host
long
emerg
somehow
cross
human
host
sever
month
ago
either
sudden
bottleneck
mutat
event
rna
recombin
event
unknown
sourc
demonstr
sarscov
possess
abil
infect
macaqu
display
symptom
similar
clinic
sign
sar
patient
replic
cat
ferret
togeth
evid
impli
phylogenet
studi
tempt
identifi
possibl
anim
reservoir
coronaviru
recent
studi
domest
wild
anim
guangdong
sar
epidem
first
report
identifi
exist
sarscov
sever
anim
found
livestock
market
includ
himalayan
palm
civet
paguma
larvata
raccoon
dog
nyctereut
procyonoid
ref
spite
failur
anoth
group
identifi
sarscov
screen
anim
speci
genom
sequenc
coronavirus
isol
anim
almost
ident
sarscov
reveal
extrem
close
phylogenet
relationship
anoth
major
find
sequenc
analysi
highlight
delet
upstream
n
gene
note
one
guangdong
isol
avail
genbank
access
number
delet
lead
fusion
two
orf
identifi
mrna
one
orf
yet
biolog
signific
remain
elucid
comparison
gene
nucleotid
sequenc
anim
human
sarscov
indic
consist
nucleotid
signatur
mutat
appear
distinguish
phylogenet
analysi
gene
sequenc
human
anim
sarscov
like
rule
possibl
consequ
human
anim
transmiss
impli
infect
anim
may
acquir
viru
true
anim
sourc
yet
identifi
also
support
hostassoci
analysi
coronavirus
base
nucleocapsid
gene
pinpoint
hostshift
play
import
role
evolut
viru
host
occurr
avianmamm
hostshift
support
hypothesi
sarscov
emerg
unknown
anim
coronaviru
revers
genet
system
use
tool
studi
function
viral
protein
mutat
firstli
describ
master
group
mhv
coronavirida
less
six
month
sinc
first
identif
sarscov
yount
et
al
develop
revers
genet
system
coronaviru
use
fulllength
cdna
clone
urbani
strain
combin
six
compon
clone
span
entir
genom
follow
vitro
transcript
transfect
result
rna
transcript
rescu
recombin
viru
found
capabl
replic
way
wild
type
expect
marker
mutat
introduc
also
identifi
success
experi
offer
hope
develop
attenu
strain
live
vaccin
sarscov
consider
scientif
interest
identif
genet
agent
respons
unusu
suscept
sarscov
ethnic
group
molecular
survey
hla
system
common
method
adopt
identifi
autoimmun
disord
emerg
infecti
diseas
conduct
taiwan
sar
epidem
use
pcr
amplif
plu
sequencespecif
oligonucleotid
probe
pcrssop
research
identifi
hla
genotyp
sar
patient
healthi
unrel
taiwanes
use
control
hla
genotyp
sar
patient
compar
probabl
case
highrisk
uninfect
health
care
worker
result
indic
higher
frequenc
hlab
allel
found
sever
sar
case
may
explain
sever
sar
patient
genotyp
state
report
common
southern
han
chines
singaporean
vietnames
indigen
taiwanes
report
sar
case
within
latter
ethnic
group
find
may
explain
unusu
sar
epidem
south
asia
work
develop
laboratori
diagnosi
sarscov
began
immedi
sar
outbreak
although
ideal
diagnost
system
still
sought
numer
protocol
develop
diagnosi
infecti
viral
diseas
protocol
pcrbase
remaind
depend
measur
immun
respons
sever
factor
affect
choic
proper
diagnosi
techniqu
includ
time
avail
equip
expertis
biolog
natur
avail
sampl
requir
data
output
format
tabl
ref
presenc
viru
detect
molecular
test
pcr
viru
isol
measur
immun
respons
basic
reli
sarscov
specif
antibodi
enzymelink
immunosorb
assay
elisa
advanc
made
molecular
diagnost
techniqu
recent
year
rapid
sensit
method
allow
effici
monitor
infecti
viral
diseas
sar
first
genet
fragment
viru
gener
revers
transcriptasepolymeras
chain
reaction
rtpcr
ref
two
rtpcr
protocol
develop
two
sar
network
laboratori
http
wwwwhointcsrsarsprimersen
sensit
assay
demonstr
least
highest
percentag
found
throat
swab
specimen
fals
posit
found
assay
first
rapid
realtim
assay
develop
base
conserv
region
gene
sequenc
person
confirm
infect
sarscov
viral
rna
detect
either
two
pcr
assay
two
aliquot
specimen
two
set
primer
http
wwwcdcgovnci
dodsarsspecimen
collect
second
gener
test
protocol
detect
exist
viru
within
day
onset
fever
provid
sensit
specif
test
npa
sampl
collect
sar
patient
within
three
day
onset
diseas
increas
sensit
onestep
realtim
rtpcr
recent
develop
specif
pcr
enhanc
coupl
use
addit
amplif
target
use
viru
n
gene
fragment
theoret
abund
subgenom
mrna
produc
transcript
techniqu
provid
inform
viral
load
antivir
treatment
real
time
efficaci
therapi
evalu
howev
although
pcr
assay
power
perform
also
technic
demand
labor
intens
develop
microarray
technolog
viral
discoveri
firstli
describ
wang
et
al
capabl
rapid
high
throughout
screen
unknown
viral
pathogen
give
great
potenti
use
diagnost
tool
identif
sarscov
wang
et
al
employ
use
improv
microarray
platform
compris
conserv
virus
character
coronaviru
genom
four
hybrid
oligonucleotid
astrovirida
share
motif
three
coronavirida
share
conserv
fragment
firstli
recogn
experi
sequenc
recov
surfac
microarray
confirm
member
coronaviru
famili
ident
sarscov
confirm
within
hour
feat
follow
partial
sequenc
novel
viru
day
later
techniqu
demonstr
rapid
accur
mean
unknown
viru
character
genet
data
viru
isol
cell
cultur
use
extens
tradit
techniqu
virolog
coronaviru
present
clinic
specimen
sar
patient
detect
inocul
clinic
specimen
cell
cultur
allow
infect
subsequ
isol
viru
fetal
rhesu
kidney
ref
vero
cell
found
suscept
sarscov
infect
isol
procedur
pathogen
identifi
sarscov
test
electron
microscopi
rtpcr
immunofluoresc
viral
antigen
detect
viru
isol
mean
detect
exist
live
viru
tissu
methodolog
gener
employ
preliminari
identif
unknown
pathogen
procedur
requir
skill
technician
time
consum
requir
infecti
virus
durat
live
viru
exist
vari
add
problem
conduct
assay
nevertheless
high
specif
n
protein
usual
chosen
antigen
anticoronaviru
antibodi
detect
assay
believ
predomin
antigen
sarscov
also
viral
protein
recogn
acut
earli
convalesc
sera
patient
recov
sar
addit
n
protein
protein
sarscov
also
report
antigen
elicit
antibodi
human
bodi
much
lower
titer
n
protein
assay
base
presenc
sarscov
antibodi
suggest
valid
specimen
obtain
three
week
onset
fever
although
patient
detect
sarscov
antibodi
within
day
onset
ill
nevertheless
neg
result
ie
absenc
sarscov
antibodi
within
first
three
week
conclud
patient
free
viru
though
elisa
method
still
defin
good
standard
rapid
diagnosi
sar
seroconvers
neg
posit
fourfold
rise
antibodi
titer
acut
convalesc
serum
indic
recent
infect
http
wwwwhointcsrsarsdiagnostictestsen
epidemiolog
sar
extens
investig
sinc
outbreak
sar
novemb
guangdong
tradit
method
use
access
epidemiolog
sar
initi
molecular
epidemiolog
use
trace
diseas
transmiss
use
phylogenet
analysi
viral
nucleotid
sequenc
quickli
identifi
aid
monitor
transmiss
coronaviru
variat
spike
protein
drastic
affect
viral
entri
pathogenesi
antivir
immun
respons
virul
cellular
even
speci
tropism
gene
use
target
genotyp
coronavirus
like
human
coronavirus
ibv
studi
ntermin
region
sarscov
spike
protein
produc
similar
conclus
convent
epidemiolog
method
investig
includ
collect
gene
sequenc
sar
patient
hong
kong
guangdong
februaryapril
mainli
direct
sequenc
rtpcr
product
deriv
clinic
specimen
compar
phylogenet
addit
sequenc
avail
genbank
major
hong
kong
virus
includ
larg
outbreak
highris
apart
block
amoy
garden
cluster
singl
index
case
came
guangdong
hong
kong
late
februari
figur
virus
deriv
hong
kong
patient
belong
lineag
virus
deriv
hong
kong
index
case
outbreak
canada
singapor
taiwan
vietnam
also
deriv
sarscov
initi
viru
lineag
judg
phylogenet
analysi
number
virus
deriv
earli
patient
exclud
major
lineag
form
distinct
cluster
impli
multipl
introduct
viru
occur
although
virus
caus
largescal
outbreak
viral
sequenc
identifi
guangdong
beij
genet
divers
impli
sarscov
circul
introduct
hong
kong
hong
kong
index
case
initi
first
superspread
incid
affect
patient
might
simpli
matter
chanc
virus
found
patient
contagi
initi
superspread
event
still
need
investig
apart
find
indic
possibl
transmiss
rout
transit
isol
possess
characterist
two
lineag
also
identifi
ruan
et
al
tsui
et
al
perform
similar
analysi
base
comparison
full
genom
sequenc
differ
sarscov
isol
independ
identifi
variat
guan
et
al
chiu
et
al
recent
identifi
nucleotid
substitut
gene
uniqu
taiwan
isol
link
hong
kong
index
case
sequenc
comparison
amoy
garden
isol
reveal
signific
variat
within
gene
across
whole
genom
impli
nonvir
factor
may
contribut
abnorm
transmiss
clinic
present
sar
cluster
highris
apart
summari
transmiss
rout
sarscov
differ
countri
area
correl
well
tradit
epidemiolog
find
impli
success
applic
molecular
epidemiolog
techniqu
trace
viru
transmiss
histori
concern
viral
evolut
zeng
et
al
perform
linear
regress
analysi
tri
estim
last
appear
sarscov
common
ancestor
effort
success
appli
time
ancestr
sequenc
human
immunodefici
viru
hiv
ref
ancestr
sequenc
believ
appear
last
late
preliminari
find
provid
import
inform
trace
origin
sarscov
monitor
spread
current
knowledg
coronaviru
immun
mainli
acquir
research
anim
coronavirus
clinic
observ
shown
humor
cellmedi
immun
respons
may
necessari
sarscov
infect
report
cell
deplet
observ
earli
infect
level
return
normal
diseas
improv
igg
antibodi
could
detect
day
onset
symptom
kept
high
titer
least
three
month
anoth
report
indic
viru
still
detect
respiratori
stool
specimen
rtpcr
diagnosi
could
cultur
day
present
impli
antibodi
could
stimul
rapidli
might
restrict
viru
infect
howev
also
report
fowl
felin
coronavir
diseas
lowlevel
antibodi
may
exacerb
diseas
therefor
import
conduct
investig
immun
respons
sar
patient
futur
benefit
vaccin
develop
diseas
control
concern
candid
target
vaccin
develop
unit
spike
protein
identifi
host
protect
antigen
use
vaccin
candid
coronavirus
extens
structur
analysi
correspond
pro
branch
length
show
genet
distanc
refer
horizont
scale
bar
sampl
name
hidden
conveni
display
except
index
case
isol
gray
subclust
transit
isol
dark
locat
isol
tree
pinpoint
dot
besid
name
hypothet
common
ancestor
subclust
highlight
describ
right
bottom
figur
tein
sar
thu
desir
identif
sarscov
function
receptor
map
receptorbind
domain
spike
protein
subunit
vaccin
target
receptorbind
domain
prepar
kill
attenu
vaccin
use
express
cell
line
may
promis
antivir
drug
repres
altern
antisar
strategi
vaccin
inhibit
chemic
target
sarscov
replicationrel
protein
consid
antisarscov
drug
candid
eg
inhibit
enzymat
activ
pro
extens
structur
analysi
pro
encod
orf
perform
pro
structur
show
consider
degre
conserv
substratebind
site
evid
could
retain
proteolyt
activ
upon
tgev
transmiss
gastroenter
viru
main
proteinas
though
anoth
group
mention
inact
properti
enzym
might
exist
vitro
result
author
suggest
use
rhinoviru
pro
inhibitor
might
use
antisar
therapi
two
month
later
research
group
us
conduct
studi
interact
two
chemic
avlqsgfr
octapeptid
pro
highlight
import
main
proteinas
target
antivir
drug
design
fan
et
al
provid
valuabl
addit
inform
conclud
dimer
form
pro
activ
proteinasesubstr
interact
speed
betasheetlik
structur
involv
substrat
recent
crystal
structur
pro
report
yang
et
al
pro
crystal
underw
conform
chang
differ
ph
condit
complex
specif
inhibitor
time
serineproteas
fold
cyshi
activ
site
recogn
hand
model
structur
domain
locat
propos
von
grotthuss
et
al
use
juri
system
high
reliabl
juri
score
conserv
uniqu
tetrad
residu
kdke
domain
assign
propos
mrna
cap
methyl
function
domain
suggest
altern
target
antivir
drug
design
addit
main
proteas
block
viru
entri
consid
well
structur
analysi
domain
sarscov
protein
play
role
fusion
viru
host
cell
reveal
conserv
sequenc
motif
wellstudi
protein
virus
class
transmembran
domain
structur
may
anoth
target
drug
design
collabor
effort
global
scientif
commun
provid
invalu
insight
molecular
biolog
sarscov
develop
rapid
accur
method
diagnosi
base
molecular
find
help
identifi
sar
patient
earli
stage
diseas
therebi
provid
valuabl
inform
nation
author
monitor
spread
diseas
take
effect
quarantin
measur
contribut
understand
clinic
present
syndrom
elucid
molecular
biolog
sarscov
provid
foundat
vaccin
design
narrow
target
largescal
high
throughput
drug
screen
program
antivir
therapi
advanc
help
global
commun
contain
spread
sar
within
four
month
sinc
first
identif
howev
much
remain
discov
novel
coronaviru
may
yet
pose
seriou
threat
unlik
recent
identifi
viral
diseas
like
ebola
west
nile
viru
seem
transmiss
sarscov
need
visibl
vector
spread
tini
invis
respiratori
droplet
suffici
infect
anoth
person
nearli
undetect
symptom
present
recent
confirm
sar
case
singapor
suggest
viru
may
continu
circul
undetect
possibl
common
domest
anim
also
viru
reservoir
sar
complic
struggl
contain
ultim
erad
diseas
aspect
sensit
accur
rapid
diagnosi
play
extrem
import
role
limit
diseas
spread
especi
develop
world
dens
popul
countri
luckili
aggress
quarantin
measur
impos
prove
effect
contain
outbreak
experi
gain
last
sar
outbreak
prepar
us
face
anoth
outbreak
confid
nevertheless
nobodi
predict
exactli
effect
vaccin
antivir
drug
develop
said
base
grow
knowledg
molecular
epidemiolog
evolut
viru
success
develop
countermeasur
sar
possibl
